title: Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis.
abstract: Pulmonary toxicity and blood dyscrasias are rare side effects of sulfasalazine. Pulmonary pathology is variable, the most common being eosinophilic pneumonia with peripheral eosinophilia, and interstitial inflammation with or without fibrosis. We here present the case of a 68-year-old female patient treated for 6 months with sulfasalazine for rheumatoid arthritis. On laboratory examination, eosinophil count was 97 x 10(3) mm(3). Thorocoscopic biopsy was performed. Histopathologic diagnosis was bronchiolitis obliterans organizing pneumonia (BOOP). This is the first case in the literature to present with sulfasalazine-induced BOOP in a patient with seronegative RA.
authors.affiliation: Department of Chest Disease, Faculty of Medicine, Mersin University, Koy-Tür (2) Sitesi, B(2) Blok, Daire 4, D.Tepe, 33320 Mersin, Turkey. baharulubas@hotmail.com
authors.forename: Bahar
authors.initials: B
authors.lastname: Ulubaş
authors.forename: Günşah
authors.initials: G
authors.lastname: Sahin
authors.forename: Caner
authors.initials: C
authors.lastname: Ozer
authors.forename: Ozlem
authors.initials: O
authors.lastname: Aydin
authors.forename: Eylem
authors.initials: E
authors.lastname: Ozgür
authors.forename: Demir
authors.initials: D
authors.lastname: Apaydin
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D018549:Cryptogenic Organizing Pneumonia / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D011239:Prednisolone / Q000627:therapeutic use; D012460:Sulfasalazine / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D012460:Sulfasalazine; D011239:Prednisolone